Minerva Neurosciences | Stammkapital

Aktienkurs
6.33
Täglich Wechseln
0.02 0.32%
Monatlich
46.53%
Jährlich
222.96%
Q1 Prognose
2.46




Stammkapital Veränderung Datum
Acadia Pharmaceuticals USD 168.71M 104K 2025-09
Adma Biologics USD 236.62M 242K 2024-12
ALKERMES USD 165.1M 49K 2025-09
Alterity Therapeutics Limited AUD 213.97M 144.39K 2023-06
AstraZeneca USD 1.55B 206K 2025-12
BioCryst Pharmaceuticals USD 1.9M 3K 2023-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Cipla INR 807.77M 807.43M 2025-09
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 93.54M 3.99M 2025-06
CSL USD 576M 19M 2024-12
Dynavax Technologies USD 117.23M 117.11M 2025-06
Eli Lilly USD 946.83M 354.23M 2025-06
Esperion Therapeutics USD 112K 11K 2023-09
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Grifols EUR 679.73M 0 2025-09
Halozyme Therapeutics USD 117.52M 98K 2025-09
Ionis Pharmaceuticals USD 161.14M 160.98M 2025-09
J&J USD 2.41B 584K 2025-09
Merck USD 2.49B 15.79M 2025-09
Minerva Neurosciences USD 1000 0 2024-09
Neurocrine Biosciences USD 99.7M 700K 2025-09
Novartis USD 1.94B 23.4M 2025-06
Novavax USD 1.62M 211K 2024-09
Pfizer USD 5.69B 1000K 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Takeda JPY 1.58B 2K 2025-12
Vanda Pharmaceuticals USD 58K 0 2024-12


Minerva Neurosciences Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.